Literature DB >> 23803250

Duodenal switch for intractable reflux gastroesophagitis after proximal gastrectomy.

Soutoku Someya1, Chikashi Shibata, Naoki Tanaka, Katsuyoshi Kudoh, Takeshi Naitoh, Koh Miura, Michiaki Unno.   

Abstract

Reflux gastroesophagitis is a common postgastrectomy complication after proximal gastrectomy, and conservative treatments including protease inhibitors and proton pump inhibitors are effective in most patients. Here we report a patient with severe reflux gastroesophagitis after proximal gastrectomy, in whom surgical treatment of duodenal switch was effective. An 80-year-old man complained of intractable heartburn, anorexia, and body weight loss after having undergone proximal gastrectomy, with reconstruction by esophagogastrostomy with valvuloplasty and pyloroplasty, for early gastric cancer 14 months before referral to our department. Oral administration of protease inhibitors and proton pump inhibitors was ineffective. Laboratory evaluation showed poor nutritional status. On endoscopic examination, we noted the redness, bleeding, and multiple erosions in the esophagus and the gastric remnant. He was diagnosed to have severe gastroesophagitis due to reflux of duodenal juice into the gastric remnant and esophagus. We performed duodenal switch to divert duodenal juice from the gastric remnant and esophagus; the duodenum was transected 2 cm distal to the pylorus, the duodenal distal end was closed, and a 50-cm Roux limb from the proximal jejunum was anastomosed to the proximal end of the duodenum. The heartburn disappeared postoperatively, and endoscopic examination revealed marked improvement of the reflux gastroesophagitis. One year postoperatively, the patient is free from symptoms including heartburn. His body weight increased, and laboratory data showed improvement in nutritional status. In conclusion, the duodenal switch may be surgical treatment of choice for intractable reflux gastroesophagitis after proximal gastrectomy.

Entities:  

Mesh:

Year:  2013        PMID: 23803250     DOI: 10.1620/tjem.230.129

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

1.  Using of Ileucecal Interposition as a Neo-stomach in Dogs with Total Gastrectomy (Presentation of a Novel Technique).

Authors:  Ehsan Soltani; Ahmad Reza Mohamadnia; Faezeh Alipour; Monavar Afzal Aghaei; Samaneh Ghasemi; Ali Sadrizadeh
Journal:  Indian J Surg       Date:  2016-05-17       Impact factor: 0.656

Review 2.  Treatment of gastric cancer.

Authors:  Michele Orditura; Gennaro Galizia; Vincenzo Sforza; Valentina Gambardella; Alessio Fabozzi; Maria Maddalena Laterza; Francesca Andreozzi; Jole Ventriglia; Beatrice Savastano; Andrea Mabilia; Eva Lieto; Fortunato Ciardiello; Ferdinando De Vita
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

3.  Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat model.

Authors:  Yuki Yamasaki; Takashi Fujimura; Katsunobu Oyama; Yuki Higashi; Atsushi Hirose; Tomoya Tsukada; Koichi Okamoto; Jun Kinoshita; Keishi Nakamura; Tomoharu Miyashita; Hidehiro Tajima; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Tetsuo Ohta
Journal:  Biomed Rep       Date:  2016-05-23

4.  Reconstruction Methods and Complications of Esophagogastrostomy and Jejunal Interposition in Proximal Gastrectomy for Gastric Cancer: A Meta-Analysis.

Authors:  Nan Du; Pei Wu; Pengliang Wang; Yuwei Du; Kai Li; Zhenning Wang; Huimian Xu; Zhi Zhu
Journal:  Gastroenterol Res Pract       Date:  2020-01-16       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.